Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017.

Chiong E., Murphy D. G., Akaza H., Buchan N. C., Chung B. H., Kanesvaran R., ...More

BJU international, vol.123, no.1, pp.22-34, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 123 Issue: 1
  • Publication Date: 2019
  • Doi Number: 10.1111/bju.14489
  • Journal Name: BJU international
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Page Numbers: pp.22-34
  • Keywords: advanced prostate cancer, castration-naive prostate cancer, castration-resistant prostate cancer, high-risk localised prostate cancer, oligometastatic prostate cancer, cost and access to treatment, ACETATE PLUS PREDNISONE, POST-HOC ANALYSIS, ABIRATERONE ACETATE, CHEMOTHERAPY-NAIVE, DOUBLE-BLIND, RADICAL PROSTATECTOMY, SURVIVAL ANALYSIS, PREVAIL TRIAL, PHASE-II, CASTRATION
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes


ObjectiveThe Asia Pacific Advanced Prostate Cancer Consensus Conference (APAC APCCC 2018) brought together 20 experts from 15 APAC countries to discuss the real-world application of consensus statements from the second APCCC held in St Gallen in 2017 (APCCC 2017).